{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:50:29Z","timestamp":1787165429815,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11686-025-01145-5","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T11:00:45Z","timestamp":1762772445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Systematic Review about the Efficacy of Antiparasitic Agents in the Treatment of  Blastocystis Species"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-5703","authenticated-orcid":false,"given":"\u00d6zlem","family":"Ulusan Ba\u011fc\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclay","family":"Aral Akarsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"8","key":"1145_CR1","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/pathogens12081050","volume":"12","author":"M Rudzi\u0144ska","year":"2023","unstructured":"Rudzi\u0144ska M, Sikorska K (2023) Epidemiology of Blastocystis infection: a review of data from Poland in relation to other reports. Pathogens 12(8):1050. https:\/\/doi.org\/10.3390\/pathogens12081050","journal-title":"Pathogens"},{"issue":"2","key":"1145_CR2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3947\/ic.2021.0004","volume":"53","author":"MX Robles-Cabrera","year":"2021","unstructured":"Robles-Cabrera MX, Magui\u00f1a JL, Gonzales-Huerta L, Panduro-Correa V, D\u00e1maso-Mata B, Pecho-Silva S, Navarro-Solsol AC, Rabaan AA, Rodr\u00edguez-Morales AJ, Arteaga-Livias K (2021) Blastocystis species and gastrointestinal symptoms in Peruvian adults attended in a public hospital. Infect Chemother 53(2):374\u2013380. https:\/\/doi.org\/10.3947\/ic.2021.0004","journal-title":"Infect Chemother"},{"key":"1145_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21911\/aai.2025.672","volume":"23","author":"\u00d6 Ulusan Ba\u011fc\u0131","year":"2025","unstructured":"Ulusan Ba\u011fc\u0131 \u00d6, \u00c7elebi S\u00f6zener Z, Bavbek S, Aral Akarsu G (2025) An Overview on Blastocystis spp: The Potential Hidden Cause of Chronic Urticaria. Asthma Allergy Immunol 23:22\u201331. https:\/\/doi.org\/10.21911\/aai.2025.672","journal-title":"Asthma Allergy Immunol"},{"key":"1145_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.641483","volume":"12","author":"V Billy","year":"2021","unstructured":"Billy V, Lhotsk\u00e1 Z, Jirk\u016f M, Kadlecov\u00e1 O, Frgelecov\u00e1 L, Parfrey LW, Pomajb\u00edkov\u00e1 KJ (2021) Blastocystis colonization alters the gut microbiome and in some cases, promotes faster recovery from induced colitis. Front Microbiol 12:641483. https:\/\/doi.org\/10.3389\/fmicb.2021.641483","journal-title":"Front Microbiol"},{"issue":"6","key":"1145_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12061084","volume":"12","author":"C Matovelle","year":"2024","unstructured":"Matovelle C, Qu\u00edlez J, Tejedor MT, Beltr\u00e1n A, Chueca P, Monteagudo LV (2024) Subtype distribution of Blastocystis spp. in patients with gastrointestinal symptoms in northern Spain. Microorganisms 12(6):1084. https:\/\/doi.org\/10.3390\/microorganisms12061084","journal-title":"Microorganisms"},{"key":"1145_CR6","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2025006","volume":"32","author":"Z Cui","year":"2025","unstructured":"Cui Z, Huang X, Zhang S, Li K, Zhang A, Li Q, Zhang Y, Li J, Qi M (2025) Molecular characterization and subtype analysis of Blastocystis sp. in captive wildlife in Henan, China. Parasite 32:11. https:\/\/doi.org\/10.1051\/parasite\/2025006","journal-title":"Parasite"},{"key":"1145_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/ajrid\/2019\/v2i330105","volume":"2","author":"V Kantardjiev","year":"2019","unstructured":"Kantardjiev V, Galev A, Broshtilova V (2019) Urticaria associated with amoeboid forms of Blastocystis spp. Asian J Res Infect Dis 2:1\u20134. https:\/\/doi.org\/10.9734\/ajrid\/2019\/v2i330105","journal-title":"Asian J Res Infect Dis"},{"key":"1145_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1128\/CMR.00022-08","volume":"21","author":"KS Tan","year":"2008","unstructured":"Tan KS (2008) New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 21:639\u2013665. https:\/\/doi.org\/10.1128\/CMR.00022-08","journal-title":"Clin Microbiol Rev"},{"key":"1145_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/MCG.0b013e3181bb86ba","volume":"44","author":"CR Stensvold","year":"2010","unstructured":"Stensvold CR, Smith HV, Nagel R, Olsen KE, Traub RJ (2010) Eradication of Blastocystis carriage with antimicrobials: reality or delusion. J Clin Gastroenterol 44:85\u201390. https:\/\/doi.org\/10.1097\/MCG.0b013e3181bb86ba","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"1145_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/09674845.2004.11732647","volume":"61","author":"J Yakoob","year":"2004","unstructured":"Yakoob J, Jafri W, Jafri N, Islam M, Beg MA (2004) In vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome. Br J Biomed Sci 61(2):75\u201377. https:\/\/doi.org\/10.1080\/09674845.2004.11732647","journal-title":"Br J Biomed Sci"},{"issue":"1","key":"1145_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/cid\/cir810","volume":"54","author":"CM Coyle","year":"2012","unstructured":"Coyle CM, Varughese J, Weiss LM, Tanowitz HB (2012) Blastocystis: to treat or not to treat. Clin Infect Dis 54(1):105\u2013110. https:\/\/doi.org\/10.1093\/cid\/cir810","journal-title":"Clin Infect Dis"},{"key":"1145_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-019-0287-8","volume":"11","author":"M Lepczy\u0144ska","year":"2019","unstructured":"Lepczy\u0144ska M, Dzika E (2019) The influence of probiotic bacteria and human gut microorganisms causing opportunistic infections on Blastocystis ST3. Gut Pathog 11:6. https:\/\/doi.org\/10.1186\/s13099-019-0287-8","journal-title":"Gut Pathog"},{"key":"1145_CR13","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ"},{"issue":"1","key":"1145_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.18502\/ijpa.v18i1.12379","volume":"18","author":"SM Abdo","year":"2023","unstructured":"Abdo SM, Ghallab MMI, Zaghloul MS, Elhadad H (2023) Efficacy of nitazoxanide, nitazoxanide-garlic combination and tinidazole in treatment of Giardia duodenalis and Blastocystis hominis: coproscopic assessment. Iran J Parasitol 18(1):48\u201355. https:\/\/doi.org\/10.18502\/ijpa.v18i1.12379","journal-title":"Iran J Parasitol"},{"issue":"1","key":"1145_CR15","doi-asserted-by":"publisher","first-page":"taac143","DOI":"10.1093\/jtm\/taac143","volume":"30","author":"LG Cobuccio","year":"2023","unstructured":"Cobuccio LG, Laurent M, Gardiol C, Wampfler R, Poppert S, Senn N, Eperon G, Genton B, Locatelli I, de Valli\u00e8re S (2023) Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial. J Travel Med 30(1):taac143. https:\/\/doi.org\/10.1093\/jtm\/taac143","journal-title":"J Travel Med"},{"issue":"4","key":"1145_CR16","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s12639-021-01398-7","volume":"45","author":"HS Ibrahim","year":"2021","unstructured":"Ibrahim HS, Salem AI, Ahmed NAME, El-Taweel HA (2021) Pre-and post-treatment evaluation of intestinal inflammation in Giardia and Blastocystis infected children: a community-based study. J Parasit Dis 45(4):1026\u20131033. https:\/\/doi.org\/10.1007\/s12639-021-01398-7","journal-title":"J Parasit Dis"},{"issue":"2","key":"1145_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1099\/jmm.0.065508-0","volume":"63","author":"T Roberts","year":"2014","unstructured":"Roberts T, Ellis J, Harkness J, Marriott D, Stark D (2014) Treatment failure in patients with chronic Blastocystis infection. J Med Microbiol 63(2):252\u2013257. https:\/\/doi.org\/10.1099\/jmm.0.065508-0","journal-title":"J Med Microbiol"},{"key":"1145_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13099-014-0034-0","volume":"6","author":"R Nagel","year":"2014","unstructured":"Nagel R, Bielefeldt-Ohmann H, Traub R (2014) Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients. Gut Pathog 6:34. https:\/\/doi.org\/10.1186\/s13099-014-0034-0","journal-title":"Gut Pathog"},{"issue":"11","key":"1145_CR19","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1445-5994.2011.02626.x","volume":"42","author":"R Nagel","year":"2012","unstructured":"Nagel R, Cuttell L, Stensvold CR, Mills PC, Bielefeldt-Ohmann H, Traub RJ (2012) Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy. Intern Med J 42(11):1187\u20131195. https:\/\/doi.org\/10.1111\/j.1445-5994.2011.02626.x","journal-title":"Intern Med J"},{"issue":"5","key":"1145_CR20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/MPG.0b013e31823a29a7","volume":"54","author":"K Heyland","year":"2012","unstructured":"Heyland K, Friedt M, Buehr P, Braegger CP (2012) No advantage for antibiotic treatment over placebo in Blastocystis hominis-positive children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr 54(5):677\u2013679. https:\/\/doi.org\/10.1097\/MPG.0b013e31823a29a7","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"1145_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00436-010-2095-4","volume":"108","author":"EC Dinleyici","year":"2011","unstructured":"Dinleyici EC, Eren M, Dogan N, Reyhanioglu S, Yarg\u0131\u00e7 ZA, Vandenplas Y (2011) Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitol Res 108(3):541\u2013545. https:\/\/doi.org\/10.1007\/s00436-010-2095-4","journal-title":"Parasitol Res"},{"issue":"4","key":"1145_CR22","first-page":"270","volume":"33","author":"S Ertu\u011f","year":"2009","unstructured":"Ertu\u011f S, Dost T, Ertabaklar H, G\u00fcltekin B (2009) The effect of trimethoprim-sulfamethoxazole in Blastocystis hominis infection. Turkiye Parazitol Derg 33(4):270\u2013272","journal-title":"Turkiye Parazitol Derg"},{"issue":"4","key":"1145_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00436-005-1363-1","volume":"96","author":"DD Moghaddam","year":"2005","unstructured":"Moghaddam DD, Ghadirian E, Azami M (2005) Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim\/sulfamethoxazole. Parasitol Res 96(4):273\u2013275. https:\/\/doi.org\/10.1007\/s00436-005-1363-1","journal-title":"Parasitol Res"},{"issue":"10","key":"1145_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/s1542-3565(05)00427-1","volume":"3","author":"JF Rossignol","year":"2005","unstructured":"Rossignol JF, Kabil SM, Said M, Samir H, Younis AM (2005) Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 3(10):987\u2013991. https:\/\/doi.org\/10.1016\/s1542-3565(05)00427-1","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1145_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2310\/7060.2003.31714","volume":"10","author":"L Nigro","year":"2003","unstructured":"Nigro L, Larocca L, Massarelli L, Patamia I, Minniti S, Palermo F, Cacopardo B (2003) A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 10(2):128\u2013130. https:\/\/doi.org\/10.2310\/7060.2003.31714","journal-title":"J Travel Med"},{"issue":"11","key":"1145_CR26","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1111\/j.1572-0241.1999.01529.x","volume":"94","author":"UZ Ok","year":"1999","unstructured":"Ok UZ, Girginkarde\u015fler N, Balc\u0131o\u011flu C, Ertan P, P\u0131r\u0131ldar T, Kilimcio\u011flu AA (1999) Effect of trimethoprim-sulfamethoxazole in Blastocystis hominis infection. Am J Gastroenterol 94(11):3245\u20133247. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01529.x","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1145_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1440-00979.x","volume":"14","author":"SY Guirges","year":"1987","unstructured":"Guirges SY, Al-Waili NS (1987) Blastocystis hominis: evidence for human pathogenicity and effectiveness of metronidazole therapy. Clin Exp Pharmacol Physiol 14(4):333\u2013335. https:\/\/doi.org\/10.1111\/j.1440-00979.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"1145_CR28","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1007\/s00436-018-5948-x","volume":"117","author":"A Rajamanikam","year":"2018","unstructured":"Rajamanikam A, Kumar S, Samudi C, Kudva M (2018) Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies. Parasitol Res 117(8):2585\u20132590. https:\/\/doi.org\/10.1007\/s00436-018-5948-x","journal-title":"Parasitol Res"},{"key":"1145_CR29","first-page":"29","volume":"26","author":"S Hunter","year":"2014","unstructured":"Hunter S (2014) The integrated treatment of Blastocystis hominis in a patient with ulcerative colitis: a case study. Aust J Herbal Med 26:29\u201333","journal-title":"Aust J Herbal Med"},{"issue":"3","key":"1145_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1179\/136485908X278847","volume":"102","author":"CR Stensvold","year":"2008","unstructured":"Stensvold CR, Arendrup MC, Nielsen HV, Bada A, Thorsen S (2008) Symptomatic infection with Blastocystis sp. subtype 8 successfully treated with trimethoprim-sulfamethoxazole. Ann Trop Med Parasitol 102(3):271\u2013274. https:\/\/doi.org\/10.1179\/136485908X278847","journal-title":"Ann Trop Med Parasitol"},{"issue":"9","key":"1145_CR31","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.26538\/tjnpr\/v6i9.18","volume":"6","author":"HS Sadoon","year":"2022","unstructured":"Sadoon HS (2022) Experimental trial of probiotics as a treatment for Blastocystis hominis in Mice. Trop J Nat Prod Res. 6(9):1443\u20131445","journal-title":"Trop J Nat Prod Res."},{"key":"1145_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-022-05418-0","volume":"15","author":"F Franklin","year":"2022","unstructured":"Franklin F, Rajamanikam A, Raju CS, Gill JS, Francis B, Sy-Cherng LW, Kumar S (2022) Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients. Parasit Vectors 15:313. https:\/\/doi.org\/10.1186\/s13071-022-05418-0","journal-title":"Parasit Vectors"},{"issue":"1","key":"1145_CR33","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.1038\/s41598-021-81418-x","volume":"11","author":"S Girish","year":"2021","unstructured":"Girish S, Kumar S, Aminudin N, Hashim NM (2021) Comparison of apoptotic responses in Blastocystis sp. upon treatment with Tongkat Ali and metronidazole. Sci Rep 11(1):7833. https:\/\/doi.org\/10.1038\/s41598-021-81418-x","journal-title":"Sci Rep"},{"key":"1145_CR34","doi-asserted-by":"publisher","first-page":"105384","DOI":"10.1016\/j.actatropica.2020.105384","volume":"204","author":"E Kordestani Shargh","year":"2020","unstructured":"Kordestani Shargh E, Pirestani M, Sadraei J (2020) In vitro toxicity evaluation of short cationic antimicrobial peptide (CM11) on Blastocystis sp. Acta Trop 204:105384. https:\/\/doi.org\/10.1016\/j.actatropica.2020.105384","journal-title":"Acta Trop"},{"issue":"2","key":"1145_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212542","volume":"14","author":"A Rajamanikam","year":"2019","unstructured":"Rajamanikam A, Hooi HS, Kudva M, Samudi C, Kumar S (2019) Resistance towards metronidazole in Blastocystis sp.: a pathogenic consequence. PLoS ONE 14(2):e0212542. https:\/\/doi.org\/10.1371\/journal.pone.0212542","journal-title":"PLoS ONE"},{"issue":"3","key":"1145_CR36","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s12639-019-01118-2","volume":"43","author":"L Garc\u00eda-Flores","year":"2019","unstructured":"Garc\u00eda-Flores L, Santill\u00e1n-Ben\u00edtez JG, Cuevas-Y\u00e1\u00f1ez E, Caballero-V\u00e1squez P, Zamudio-Ch\u00e1vez S, Morales-\u00c1vila E (2019) Evaluation of the effect of 1,3-bis-(4-phenyl-[1,2,3] triazole-1-il)2-propanol in comparison with metronidazole in an in vitro culture of Blastocystis in samples of patients with irritable bowel syndrome. J Parasit Dis 43(3):506\u2013512. https:\/\/doi.org\/10.1007\/s12639-019-01118-2","journal-title":"J Parasit Dis"},{"issue":"2","key":"1145_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3347\/kjp.2018.56.2.105","volume":"56","author":"MMA Basyoni","year":"2018","unstructured":"Basyoni MMA, Fouad SA, Amer MF, Amer AF, Ismail DI (2018) Atorvastatin: in-vivo synergy with metronidazole as anti-Blastocystis therapy. Korean J Parasitol 56(2):105\u2013112. https:\/\/doi.org\/10.3347\/kjp.2018.56.2.105","journal-title":"Korean J Parasitol"},{"issue":"3","key":"1145_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21608\/puj.2018.6489.1027","volume":"11","author":"FSM Habib","year":"2018","unstructured":"Habib FSM, Abdel-Fattah N, Saad G, El Naggar H (2018) Growth kinetics and metronidazole sensitivity of Blastocystis spp. isolated from colorectal carcinoma (CRC) and non-CRC patients. Parasitol United J 11(3):175\u2013180. https:\/\/doi.org\/10.21608\/puj.2018.6489.1027","journal-title":"Parasitol United J"},{"issue":"1","key":"1145_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00436-015-4760-0","volume":"115","author":"K Raman","year":"2016","unstructured":"Raman K, Kumar S, Chye TT (2016) Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment. Parasitol Res 115(1):391\u2013396. https:\/\/doi.org\/10.1007\/s00436-015-4760-0","journal-title":"Parasitol Res"},{"issue":"8","key":"1145_CR40","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1128\/IAI.00339-16","volume":"84","author":"JA Yason","year":"2016","unstructured":"Yason JA, Ajjampur SSR, Tan KSW (2016) Blastocystis isolate B exhibits multiple modes of resistance against antimicrobial peptide LL-37. Infect Immun 84(8):2220\u20132232. https:\/\/doi.org\/10.1128\/IAI.00339-16","journal-title":"Infect Immun"},{"issue":"7","key":"1145_CR41","doi-asserted-by":"publisher","first-page":"e0155390","DOI":"10.1371\/journal.pone.0155390","volume":"11","author":"DB Dhurga","year":"2016","unstructured":"Dhurga DB, Suresh K, Tan TC (2016) Granular formation during apoptosis in Blastocystis sp. exposed to metronidazole (MTZ). PLoS ONE 11(7):e0155390. https:\/\/doi.org\/10.1371\/journal.pone.0155390","journal-title":"PLoS ONE"},{"issue":"8","key":"1145_CR42","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1128\/AAC.04832-14","volume":"59","author":"T Roberts","year":"2015","unstructured":"Roberts T, Bush S, Ellis J, Harkness J, Stark D (2015) In vitro antimicrobial susceptibility patterns of Blastocystis. Antimicrob Agents Chemother 59(8):4417\u20134423. https:\/\/doi.org\/10.1128\/AAC.04832-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1145_CR43","doi-asserted-by":"publisher","first-page":"e2885","DOI":"10.1371\/journal.pntd.0002885","volume":"8","author":"Z Wu","year":"2014","unstructured":"Wu Z, Mirza H, Tan KS (2014) Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7. PLoS Negl Trop Dis 8(5):e2885. https:\/\/doi.org\/10.1371\/journal.pntd.0002885","journal-title":"PLoS Negl Trop Dis"},{"key":"1145_CR44","doi-asserted-by":"publisher","DOI":"10.9775\/kvfd.2012.6099","author":"F Do\u011fruman Al","year":"2012","unstructured":"Do\u011fruman Al F, Ad\u0131yaman G, Yantira T, Hasg\u00fcr S, Ba\u011fr\u0131a\u00e7\u0131k \u00dc (2012) Anti-paraziter etkili ila\u00e7lar\u0131n Blastocystis izolatlar\u0131n\u0131n canl\u0131l\u0131klar\u0131 \u00fczerine etkilerinin MTT testi ile belirlenmesi. Kafkas Univ Vet Fak Derg. https:\/\/doi.org\/10.9775\/kvfd.2012.6099","journal-title":"Kafkas Univ Vet Fak Derg"},{"issue":"1","key":"1145_CR45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00436-012-2860-7","volume":"111","author":"LA Dunn","year":"2012","unstructured":"Dunn LA, Tan KS, Vanelle P, Juspin T, Crozet MD, Terme T, Upcroft P, Upcroft JA (2012) Development of metronidazole-resistant lines of Blastocystis sp. Parasitol Res 111(1):441\u2013450. https:\/\/doi.org\/10.1007\/s00436-012-2860-7","journal-title":"Parasitol Res"},{"issue":"12","key":"1145_CR46","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1128\/IAI.05632-11","volume":"79","author":"H Mirza","year":"2011","unstructured":"Mirza H, Wu Z, Kidwai F, Tan KS (2011) A metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism. Infect Immun 79(12):5019\u20135026. https:\/\/doi.org\/10.1128\/IAI.05632-11","journal-title":"Infect Immun"},{"issue":"2","key":"1145_CR47","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1128\/AAC.00900-10","volume":"55","author":"H Mirza","year":"2011","unstructured":"Mirza H, Teo JD, Upcroft J, Tan KS (2011) A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. Antimicrob Agents Chemother 55(2):637\u2013648. https:\/\/doi.org\/10.1128\/AAC.00900-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1145_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1099\/mic.0.26496-0","volume":"150","author":"AMA Nasirudeen","year":"2004","unstructured":"Nasirudeen AMA, Hian YE, Singh M, Tan KSW (2004) Metronidazole induces programmed cell death in the protozoan parasite Blastocystis hominis. Microbiology (Reading) 150(1):33\u201343. https:\/\/doi.org\/10.1099\/mic.0.26496-0","journal-title":"Microbiology (Reading)"},{"key":"1145_CR49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/PL00008533","volume":"86","author":"A Vdovenko","year":"2000","unstructured":"Vdovenko A, Williams J (2000) Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing. Parasitol Res 86:573\u2013581. https:\/\/doi.org\/10.1007\/PL00008533","journal-title":"Parasitol Res"},{"issue":"4","key":"1145_CR50","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1046\/j.1365-3156.1999.00398.x","volume":"4","author":"K Haresh","year":"1999","unstructured":"Haresh K, Suresh K, Khairul Anus A, Saminathan S (1999) Isolate resistance of Blastocystis hominis to metronidazole. Trop Med Int Health 4(4):274\u2013277. https:\/\/doi.org\/10.1046\/j.1365-3156.1999.00398.x","journal-title":"Trop Med Int Health"},{"issue":"5","key":"1145_CR51","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1365-3156.1996.tb00094.x","volume":"1","author":"V Zaman","year":"1996","unstructured":"Zaman V, Zaki M (1996) Resistance of Blastocystis hominis cysts to metronidazole. Trop Med Int Health 1(5):677\u2013678. https:\/\/doi.org\/10.1111\/j.1365-3156.1996.tb00094.x","journal-title":"Trop Med Int Health"},{"issue":"4","key":"1145_CR52","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/jac\/27.4.507","volume":"27","author":"LA Dunn","year":"1991","unstructured":"Dunn LA, Boreham PF (1991) The in-vitro activity of drugs against Blastocystis hominis. J Antimicrob Chemother 27(4):507\u2013516. https:\/\/doi.org\/10.1093\/jac\/27.4.507","journal-title":"J Antimicrob Chemother"},{"key":"1145_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2016.11.003","author":"L Batista","year":"2017","unstructured":"Batista L, P\u00e9rez Jove J, Rosinach M, Gonzalo V, Sainz E, Loras C et al (2017) Escasa eficacia de metronidazol en la erradicaci\u00f3n de Blastocystis hominis en pacientes sintom\u00e1ticos: serie de casos y revisi\u00f3n sistem\u00e1tica de la literatura. Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.gastrohep.2016.11.003","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"1145_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3347\/kjp.2020.58.3.321","volume":"58","author":"MJ Kim","year":"2020","unstructured":"Kim MJ, Won EJ, Kim SH, Shin JH, Chai JY (2020) Molecular detection and subtyping of human Blastocystis and the clinical implications: comparisons between diarrheal and non-diarrheal groups in Korean populations. Korean J Parasitol 58(3):321\u2013326. https:\/\/doi.org\/10.3347\/kjp.2020.58.3.321","journal-title":"Korean J Parasitol"},{"key":"1145_CR55","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1892\/0891-6640(2007)21[966:dotivs]2.0.co","volume":"21","author":"EJ Kather","year":"2007","unstructured":"Kather EJ, Marks SL, Kass PH (2007) Determination of the in vitro susceptibility of feline Tritrichomonas foetus to 5 antimicrobial agents. J Vet Intern Med 21:966\u2013970. https:\/\/doi.org\/10.1892\/0891-6640(2007)21[966:dotivs]2.0.co","journal-title":"J Vet Intern Med"},{"key":"1145_CR56","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jfms.2010.12.001","volume":"13","author":"DN LeVine","year":"2011","unstructured":"LeVine DN, Papich MG, Gookin JL, Davidson GS, Davis JL, Hayes RB (2011) Ronidazole pharmacokinetics after intravenous and oral immediate-release capsule administration in healthy cats. J Feline Med Surg 13:244\u2013250","journal-title":"J Feline Med Surg"},{"issue":"43","key":"1145_CR57","doi-asserted-by":"publisher","first-page":"17564","DOI":"10.1073\/pnas.1302664110","volume":"110","author":"Y Miyamoto","year":"2013","unstructured":"Miyamoto Y, Kalisiak J, Korthals K, Lauwaet T, Cheung DY, Lozano R, Cobo ER, Upcroft P, Upcroft JA, Berg DE, Gillin FD, Fokin VV, Sharpless KB, Eckmann L (2013) Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity. Proc Natl Acad Sci U S A 110(43):17564\u201317569. https:\/\/doi.org\/10.1073\/pnas.1302664110","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-025-01145-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-025-01145-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-025-01145-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:00:35Z","timestamp":1768813235000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-025-01145-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1145"],"URL":"https:\/\/doi.org\/10.1007\/s11686-025-01145-5","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}